# Trade Mark Journal No.2026/002 9 January 2026

## UK00004311848 17 December 2025 (1,5)

TRUPATH

International priority date claimed: 9 October 2025 (United States of America) (99435673)

Class 1
  Agents, reagents, assays, enzymes, nucleotides, and buffers for scientific and research use; Agents, reagents, assays, enzymes, nucleotides, and buffers for scientific and research use, in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for research and scientific purposes; Kits containing reagents, enzymes, assays, buffers and flow cells for non-medical purposes; Kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, all for research, scientific, and industrial purposes; Chemical agents and reagents used in scientific and research genetic sequencing to identify and expand scope of sequenced material.
Class 5
  Agents, reagents, assays, enzymes, nucleotides, and buffers for medical, dental, and veterinary use in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for medical purposes; Kits containing reagents, agents, enzymes, assays, buffers and flow cells for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Chemical agents and reagents for genetic sequencing to identify and expand scope of sequenced material for medical purposes in the field of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing.

Illumina, Inc.

Representative: CMS Cameron McKenna Nabarro Olswang LLP